SPOTLIGHT: Cardinal puts pharma ops on sales block


Cardinal Health says that it plans to sell its $1.8 billion pharmaceutical services arm. The group packages 100 billion doses of medicines a year for pharma and biotech companies. Cardinal Health wants to focus its business on providers like hospitals and pharmacies. Report